- Home
- IMA vs CTSO Comparison
IMA vs CTSO Comparison
Compare IMA & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMA
- CTSO
- Stock Information
- Founded
- IMA 2019
- CTSO 1997
- Country
- IMA United States
- CTSO United States
- Employees
- IMA N/A
- CTSO N/A
- Industry
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- CTSO Medical/Dental Instruments
- Sector
- IMA Health Care
- CTSO Health Care
- Exchange
- IMA Nasdaq
- CTSO Nasdaq
- Market Cap
- IMA 69.5M
- CTSO 72.8M
- IPO Year
- IMA N/A
- CTSO N/A
- Fundamental
- Price
- IMA $14.23
- CTSO $0.91
- Analyst Decision
- IMA
- CTSO Buy
- Analyst Count
- IMA 0
- CTSO 2
- Target Price
- IMA N/A
- CTSO $5.50
- AVG Volume (30 Days)
- IMA 17.7K
- CTSO 379.8K
- Earning Date
- IMA 01-01-0001
- CTSO 08-07-2025
- Dividend Yield
- IMA N/A
- CTSO N/A
- EPS Growth
- IMA N/A
- CTSO N/A
- EPS
- IMA N/A
- CTSO N/A
- Revenue
- IMA $4,300,000.00
- CTSO $36,107,520.00
- Revenue This Year
- IMA N/A
- CTSO $11.15
- Revenue Next Year
- IMA N/A
- CTSO $21.39
- P/E Ratio
- IMA N/A
- CTSO N/A
- Revenue Growth
- IMA N/A
- CTSO 20.18
- 52 Week Low
- IMA $11.65
- CTSO $0.71
- 52 Week High
- IMA $23.28
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- IMA N/A
- CTSO 44.06
- Support Level
- IMA N/A
- CTSO $0.83
- Resistance Level
- IMA N/A
- CTSO $1.19
- Average True Range (ATR)
- IMA 0.00
- CTSO 0.09
- MACD
- IMA 0.00
- CTSO -0.01
- Stochastic Oscillator
- IMA 0.00
- CTSO 21.91
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.